Search Results - "MOURAO NETTO, Mario"

Gene Expression Profile Associated with Response to Doxorubicin-Based Therapy in Breast Cancer by AZEVEDO KOIKE FOLGUEIRA, Maria Aparecida, CARRARO, Dirce Maria, REIS, Luiz Fernando, KAIANO, Jane Haruko, CAMARGO, Luiz Paulo, NICOLIELLO VENCIO, Ricardo Zorzetto, LONGO SNITCOVSKY, Igor Moysés, MAKDISSI, Fabiana Baroni, DA SILVA E SILVA, Paulo José, GUEDES SAMPAIO GOES, Joao Carlos, MITZI BRENTANI, Maria, BRENTANI, Helena, DA COSTA PATRAO, Diogo Ferreira, MANTOVANI BARBOSA, Edson, MOURAO NETTO, Mario, FIGARO CALDEIRA, José Roberto, HIRATA KATAYAMA, Maria Lucia, SOARES, Fernando Augusto, OLIVEIRA, Célia Tosello

“…Purpose: This study was designed to identify genes that could predict response to doxorubicin-based primary chemotherapy in breast cancer patients…”
Get full text

Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case‐control studies in Japanese, Japanese Brazilians and non‐Japanese Brazilians by Iwasaki, Motoki, Hamada, Gerson Shigeaki, Nishimoto, Inês Nobuko, Netto, Mario Mourão, Motola Jr, Juvenal, Laginha, Fábio Martins, Kasuga, Yoshio, Yokoyama, Shiro, Onuma, Hiroshi, Nishimura, Hideki, Kusama, Ritsu, Kobayashi, Minatsu, Ishihara, Junko, Yamamoto, Seiichiro, Hanaoka, Tomoyuki, Tsugane, Shoichiro

“…Epidemiologic studies have shown an inverse association between isoflavones and breast cancer risk. Because isoflavones bind estrogen receptors, we…”
Get full text

Dietary Isoflavone Intake, Polymorphisms in the CYP17, CYP19, 17β-HSD1, and SHBG Genes, and Risk of Breast Cancer in Case-Control Studies in Japanese, Japanese Brazilians, and Non-Japanese Brazilians by Iwasaki, Motoki, Hamada, Gerson Shigeaki, Nishimoto, Ines Nobuko, Netto, Mario Mourao, Motola, Juvenal Jr, Laginha, Fabio Martins, Kasuga, Yoshio, Yokoyama, Shiro, Onuma, Hiroshi, Nishimura, Hideki, Kusama, Ritsu, Kobayashi, Minatsu, Ishihara, Junko, Yamamoto, Seiichiro, Hanaoka, Tomoyuki, Tsugane, Shoichiro

“…We tested the hypothesis that polymorphisms in cytochrome P450c17 (CYP17), aromatase (CYP19), 17β-hydroxysteroid dehydrogenase type I (17β-HSD1) and sex…”
Get full text

Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients by Nagai, Maria Aparecida, Gerhard, Renê, Fregnani, José Humberto T. G., Nonogaki, Suely, Rierger, Regina Barbosa, Netto, Mário Mourão, Soares, Fernando A.

“…An increasing number of studies have shown altered expression of secreted protein acidic and rich in cysteine (SPARC) and N-myc down-regulated gene (NDRG1) in…”
Get full text

Dietary isoflavone intake and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians by Iwasaki, Motoki, Hamada, Gerson Shigeaki, Nishimoto, Ines Nobuko, Netto, Mario Mourão, Motola, Juvenal Jr, Laginha, Fábio Martins, Kasuga, Yoshio, Yokoyama, Shiro, Onuma, Hiroshi, Nishimura, Hideki, Kusama, Ritsu, Kobayashi, Minatsu, Ishihara, Junko, Yamamoto, Seiichiro, Hanaoka, Tomoyuki, Tsugane, Shoichiro

“…Although epidemiologic studies have shown an inverse association between isoflavones and breast cancer risk, little evidence for a dose-response relation is…”
Get full text

Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvant chemotherapy by AZEVEDO KOIKE FOLGUEIRA, Maria Aparecida, BRENTANI, Helena, MOURAO, Mario, FIGARO CALDEIRA, José Roberto, MITZI BRENTANI, Maria, CARRARO, Dirce Maria, DE CAMARGO BARROS, Mateus, HIRATA KATAYAMA, Maria Lucia, SANTANA DE ABREU, Ana Paula, MANTOVANI BARBOSA, Edson, TOSELLO DE OLIVEIRA, Celia, PATRAO, Diogo F. C, MOTA, Louise D

“…In breast cancer patients, primary chemotherapy is associated with the same survival benefits as adjuvant chemotherapy. Residual tumors represent a clinical…”
Get full text

C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer by LOGULLO, Angela F, LOPES, Andreia B. G, NONOGAKI, Suely, SOARES, Fernando A, MOURAO NETTO, Mario, NISHIMOTO, Ines N, MITZI BRENTANI, M

“…The definition of high risk patients with early stage breast cancer is still controversial. We evaluated the ability of galectin-3, c-erbB-2 and p53…”
Get full text

Down-regulation of PHLDA1 gene expression is associated with breast cancer progression by APARECIDA NAGAI, Maria, FREGNANI, José Humberto T. G, MOURAO NETTO, Mario, MITZI BRENTANI, Maria, SOARES, Fernando A

“…In a previous study, using differential display reverse transcriptase-PCR (DDRT-PCR) we showed that down-regulation of the PHLDA1 (pleckstrin homology-like…”
Get full text

Biochemical analysis of human breast tissues using Fourier-transform Raman spectroscopy by Bitar, Renata Andrade, Martinho, Herculano da Silva, Tierra-Criollo, Carlos Julio, Zambelli Ramalho, Leandra Náira, Netto, Mário Mourão, Martin, Airton Abrahão

“…We employ Fourier-transform Raman spectroscopy to study normal and tumoral human breast tissues, including several subtypes of cancers. We analyzed 194 Raman…”
Get more information

Is the expression of inducible (iNOS) and endothelial (eNOS) nitric oxide synthases an early event in breast carcinogenesis? by Carvalho, Solange Maria Torchia, Soares, Fernando Augusto, Netto, Mario Mourão, Nonogaki, Sueli, Castro, Rodrigo Aquino

Get more information

Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients by Nagai, Maria Aparecida, Gerhard, Rene, Fregnani, Jose Humberto T.G, Nonogaki, Suely, Rierger, Regina Barbosa, Netto, Mario Mourao, Soares, Fernando A

“…An increasing number of studies have shown altered expression of secreted protein acidic and rich in cysteine (SPARC) and N-myc down-regulated gene (NDRG1) in…”
Get full text

A multivariate analysis on prognostic factors for lobular carcinoma of the breast by Köhler, Hugo Fontan, Maciel, Maria do Socorro, Collins, Juan Donoso, Rozenowicz, Renato de Lima, Netto, Mário Mourão

“…Lobular carcinoma is the second most common type of breast neoplasia and has unique clinical and pathological features. Our aim was to evaluate prognostic…”
Get full text

Dietary Isoflavone Intake, Polymorphisms in the CYP17, CYP19, 17b-HSD1, and SHBG Genes, and Risk of Breast Cancer in Case-Control Studies in Japanese, Japanese Brazilians, and Non-Japanese Brazilians by Iwasaki, Motoki, Hamada, Gerson Shigeaki, Nishimoto, Ines Nobuko, Netto, Mario Mourao, Motola Jr, Juvenal, Laginha, Fabio Martins, Kasuga, Yoshio, Yokoyama, Shiro, Onuma, Hiroshi, Nishimura, Hideki, Kusama, Ritsu, Kobayashi, Minatsu, Ishihara, Junko, Yamamoto, Seiichiro, Hanaoka, Tomoyuki, Tsugane, Shoichiro

“…We tested the hypothesis that polymorphisms in cytochrome P450c17a (CYP17), aromatase (CYP19), 17*b-hydroxysteroid dehydrogenase type I (17*b-HSD1) and sex…”
Get full text

Down-regulation of the candidate tumor suppressor gene PAR-4 is associated with poor prognosis in breast cancer by NAGAI, Maria Aparecida, GERHARD, Renê, SALAORNI, Sibeli, TAVARES UERREIRO FREGNANI, José Humberto, NONOGAKI, Suely, MOURAO, Mario, SOARES, Fernando Augusto

“…Substantial experimental evidence indicates that PAWR gene (PKC apoptosis WT1 regulator; also named PAR-4, prostate apoptosis response-4) is a central player…”
Get full text

Dietary Isoflavone Intake, Polymorphisms in the CYP17, CYP19, 17[Beta]-HSD1, and SHBG Genes, and Risk of Breast Cancer in Case-Control Studies in Japanese, Japanese Brazilians, and Non-Japanese Brazilians by Iwasaki, Motoki, Hamada, Gerson Shigeaki, Nishimoto, Ines Nobuko, Netto, Mario Mourão, Motola, Juvenal, Laginha, Fábio Martins, Kasuga, Yoshio, Yokoyama, Shiro, Onuma, Hiroshi, Nishimura, Hideki, Kusama, Ritsu, Kobayashi, Minatsu, Ishihara, Junko, Yamamoto, Seiichiro, Hanaoka, Tomoyuki, Tsugane, Shoichiro

“…We tested the hypothesis that polymorphisms in cytochrome P450c17α (CYP17), aromatase (CYP19), 17α-hydroxysteroid dehydrogenase type I (17α-HSD1) and sex…”
Get full text

Aversão alimentar adquirida e qualidade de vida em mulheres com neoplasia mamária by Verde, Sara Maria Moreira Lima(Universidade de São Paulo Faculdade de Saúde Pública Departamento de Nutrição), São Pedro, Bruna Mara Okano(Universidade de São Paulo Faculdade de Saúde Pública Departamento de Nutrição), Mourão Netto, Mário(Fundação Antônio Prudente Hospital AC Camargo Departamento de Mastologia), Damasceno, Nágila Raquel Teixeira(Universidade de São Paulo Faculdade de Saúde Pública Departamento de Nutrição)

“…OBJETIVO: Avaliar o comportamento alimentar de mulheres com câncer de mama submetidas à quimioterapia, e sua relação com a qualidade de vida destas pacientes…”
Get full text

Biochemical analysis of human breast tissues using FT-Raman spectroscopy by Bitar, Renata Andrade, Martinho, Herculano da Silva, Criollo, Carlos Julio Tierra, Ramalho, Leandra Naira Zambelli, Netto, Mario Mourao, Martin, Airton Abrahao

“…In this work we employ the Fourier Transform Raman Spectroscopy to study normal and tumoral human breast tissues, including several subtypes of cancers. We…”
Get full text

Dietary isoflavone intake, polymorphisms in the CYP17, CYP19, 17beta-HSD1, and SHBG genes, and risk of breast cancer in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians by Iwasaki, Motoki, Hamada, Gerson Shigeaki, Nishimoto, Ines Nobuko, Netto, Mario Mourão, Motola, Jr, Juvenal, Laginha, Fábio Martins, Kasuga, Yoshio, Yokoyama, Shiro, Onuma, Hiroshi, Nishimura, Hideki, Kusama, Ritsu, Kobayashi, Minatsu, Ishihara, Junko, Yamamoto, Seiichiro, Hanaoka, Tomoyuki, Tsugane, Shoichiro

“…We tested the hypothesis that polymorphisms in cytochrome P450c17alpha (CYP17), aromatase (CYP19), 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1) and…”
Get full text

Aversão alimentar adquirida e qualidade de vida em mulheres com neoplasia mamária by Verde, Sara Maria Moreira Lima, São Pedro, Bruna Mara Okano, Mourão Netto, Mário, Damasceno, Nágila Raquel Teixeira

“…OBJETIVO: Avaliar o comportamento alimentar de mulheres com câncer de mama submetidas à quimioterapia, e sua relação com a qualidade de vida destas pacientes…”
Get full text